Riskpilot← Back to searchSign inGet full accessLAB7 AS
ASActiveOrg 994140965Gjerdegata 26, 6065 UlsteinvikComputer programming activities · NACE 6210Est. 20092 employees
Revenue 2024
NOK 0
EBITDA margin
—
+57% vs 2023
Equity ratio
98.1%
Financial strength
Net profit 2024
NOK -75K
+59% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -72K | +57% |
| Net profit | NOK -75K | +59% |
| Total assets | NOK 1M | -7% |
| Equity | NOK 1M | -7% |
| Employees | 2 | — |
Legal name
LAB7 AS
Org number
994140965
Legal form
Aksjeselskap
NACE code
6210 · Computer programming activities
Founded
26. mai 2009
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Fremstilling/salg av teknologiutvikling, elektronikk, programvare og andre produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lgnende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Gjerdegata 26, 6065 Ulsteinvik
Email
contactus@lab7tech.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 071 | 278 | 8 | 3 | 0 |
| Staff expenses | −780 | 4 | 7 | −40 | −4 |
| EBITDA | 61 | 57 | −137 | −168 | −72 |
| Depreciation & amort. | −12 | −19 | −17 | −7 | −0 |
| EBIT | 49 | 39 | −154 | −175 | −72 |
| Net financials | 25 | 91 | 83 | −7 | −3 |
| Profit before tax | 74 | 130 | −71 | −182 | −75 |
| Tax | 11 | 9 | −0 | −0 | −0 |
| Net profit | 64 | 121 | −71 | −182 | −75 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 364 | 1 413 | 1 292 | 1 110 | 1 031 |
| Equity | 1 219 | 1 339 | 1 268 | 1 087 | 1 011 |
| Long-term debt | 2 | 0 | 0 | 0 | 0 |
| Short-term debt | 144 | 74 | 23 | 23 | 20 |
| Total debt | 146 | 74 | 23 | 23 | 20 |
EBITDA margin
-7208000.0%
This company
15.8%
Market median
-45620353% vs market
20202024
Equity ratio
98.1%
This company
38.2%
Market median
+157% vs market
20202024
Return on equity
-7.4%
This company
18.4%
Market median
-140% vs market
20202024
Net profit margin
-7525300.0%
This company
8.1%
Market median
-92905038% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RI Chief Executive Officer | Chief Executive Officer | 2009 |
NA Deputy Member | Deputy Member | 2009 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LAB7 AS 
ENABLED ASBoard members of LAB7 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Inge Ambjørnsen | Chief Executive Officer | 0 companies |
| Nils Ambjørn Ambjørnsen | Deputy Member | 0 companies |